Alimera Sciences Inc. (ALIM) Drops 6.07% on December 22

Equities Staff |

Alimera Sciences Inc. (ALIM) was one of the Russell 2000's biggest losers for Tuesday December 22 as the stock slid 6.07% to $2.63, a loss of $-0.17 per share. Starting at an opening price of $2.83 a share, the stock traded between $2.63 and $2.86 over the course of the trading day. Volume was 91,134 shares over 323 trades, against an average daily volume of 239,626 shares and a total float of 44.55 million.

The losses send Alimera Sciences Inc. down to a market cap of $117.15 million. In the last year, Alimera Sciences Inc. has traded between $5.95 and $1.94, and its 50-day SMA is currently $3.02 and 200-day SMA is $3.88.

Alimera Sciences Inc is a pharmaceutical company. The Company, along with its subsidiaries is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals.

Alimera Sciences Inc. is based out of Alpharetta, GA and has some 105 employees. Its CEO is C. Daniel Myers.

For a complete fundamental analysis analysis of Alimera Sciences Inc., check out’s Stock Valuation Analysis report for ALIM. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Cavitation Techs Inc

Cavitation Technologies Inc engineers and designs Nano technology based systems that have potential applications in industrial liquid processing.

Private Markets


Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…